MFA Disease Interactions
There is 1 disease interaction with MFA (lactobacillus acidophilus).
Moderate
Probiotics (applies to MFA) immunosuppression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
Probiotics, especially those containing lactobacillus, should be used with caution in immunosuppressed patients.
References (3)
- "Product Information. Culturelle DS (lactobacillus rhamnosus GG)." ConAgra Functional Foods
- Salminen MK, Tynkkynen S, Rautelin H, et al. (2002) "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis, 35, p. 1155-60
- Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK (2005) "Lactobacillus sepsis associated with probiotic therapy." Pediatrics, 115, p. 178-81
Switch to consumer interaction data
MFA drug interactions
There are 351 drug interactions with MFA (lactobacillus acidophilus).
More about MFA (lactobacillus acidophilus)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.